The Centers for Medicare & Medicaid Services (CMS) have announced crucial updates to telehealth reimbursement for 2026, including a 15% increase in coverage for remote patient monitoring. This article delves into the implications for healthcare providers and patients nationwide.

The MedTech sector witnessed a remarkable 20% surge in mergers and acquisitions during the first half of 2026. This article delves into the drivers behind this trend and its multifaceted implications for market competition, innovation, and the future of healthcare in the United States.

This report details a significant 10% rise in cybersecurity breaches affecting U.S. hospitals in Q4 2026. Explore the causes, consequences, and essential strategies for healthcare organizations to enhance their digital defenses against evolving cyber threats.

On November 15, 2026, the U.S. Senate Committee on Health will debate the MedTech Innovation Act. This pivotal legislation aims to reshape medical technology development, accelerate patient access, and foster a more dynamic healthcare ecosystem. Understand its implications for the industry and patients nationwide.

The first U.S. approval for a CRISPR-based therapy is anticipated by December 2026, marking a monumental shift in treating genetic diseases. This article delves into the science, clinical trials, ethical debates, and future prospects of this revolutionary gene-editing technology.

U.S. digital health investment achieved a historic milestone in Q2 2026, reaching a staggering $12 billion. This post delves into the factors fueling this growth, the innovative technologies attracting capital, and what this means for the future of healthcare.

The FDA is set to release 8 new guidance documents on AI in medical devices by early 2027, signaling a pivotal shift in regulatory oversight. This article delves into the anticipated impact on manufacturers, developers, and healthcare providers, emphasizing safety, efficacy, and responsible innovation.

The U.S. healthcare system faces a critical challenge: a projected 5% worsening of its workforce shortage by 2026, significantly influenced by rapid technological advancements. This article delves into the multifaceted causes and potential solutions.

A leading pharmaceutical company is injecting $500 million into U.S. gene therapy research for 2026-2027, signaling a monumental leap for innovative treatments and the healthcare industry's future.

The NIH's monumental $1.5 billion investment in precision medicine, commencing January 2026, is set to redefine healthcare. This initiative will drive research into personalized treatments, leveraging individual data for more effective and targeted medical interventions, promising a new era of tailored health solutions.